Friday broker round-up UPDATE
14th Feb 2014 10:26
Assura Group: Liberum Capital shifts target price from 44p to 44.40p and retains a buy recommendation. Barclays: Credit Suisse lowers target price from 270p to 260p and keeps a neutral rating. Bellway: Panmure Gordon raises target price from 1520p to 1639p and maintains a buy recommendation. UBS i
Read moreUK stocks edge lower as investors await Eurozone GDP
14th Feb 2014 09:05
- Eurozone GDP figures ahead - Italian politics in focus as PM resigns - Miners rise strongly, banks and retailers fall techMARK 2,822.53 -0.05% FTSE 100 6,650.83 -0.13% FTSE 250 16,045.41 +0.10% UK stocks opened slightly lower on Friday morning with strong gains from mining stocks outweighed by w
Read moreUK stocks erase losses, but corporate earnings weigh on sentiment
13th Feb 2014 16:55
- Stocks snap winning streak but pare losses by the close - Tate & Lyle, Rolls-Royce issue profit warnings - Lloyds underwhelms with higher profits in 2013 - US retail sales disappoint techMARK 2,823.82 -0.26% FTSE 100 6,659.42 -0.23% FTSE 250 16,029.39 -0.31% Profit warnings from Tate & Lyle and
Read moreTullow Chairman ups investment after profit disappoints
13th Feb 2014 16:12
The Chairman of Tullow Oil has shown his faith in the company following its disappointing profit result on Wednesday. Simon Thompson purchased 6,244 shares at 796.48p a go, spending a total of £49,732. His stake in the company now stands at 20,604 shares. Meanwhile, Non-Executive Director, Jeremy
Read moreFTSE 100 movers: Rolls-Royce nosedives on 2014 outlook
13th Feb 2014 14:35
Rolls-Royce's shares tumbled after the group said it expects flat 2014 revenue and profit due to cuts in government defence spending. The world's second-largest maker of aircraft engines revealed an estimated 15-20 per cent slump in defence revenue would hinder results this year as it reported its f
Read moreBroker tips: Tate & Lyle, Aberdeen, AMEC
13th Feb 2014 12:38
Shore Capital has reiterated its 'hold' stance and sugar and sweeteners group Tate & Lyle following a 'constrained' third-quarter trading update in which it scaled back its profit guidance for the full year. The broker said has Tate & Lyle invested in its SFI infrastructure in recent years to impro
Read moreUK markets snap six-day winning streak after blue-chip profit warnings
13th Feb 2014 11:59
- Stocks snap six-day winning streak - Tate & Lyle, Rolls-Royce issue profit warnings - Lloyds underwhelms with higher profits in 2013 - Miners fall, AMEC and Imperial rise techMARK 2,811.28 -0.70% FTSE 100 6,624.61 -0.76% FTSE 250 15,968.13 -0.69% UK stocks opened firmly lower on Thursday after a
Read moreShore Capital cuts Tate & Lyle forecasts after profit warning
13th Feb 2014 10:57
Shore Capital has reiterated its 'hold' stance on sugar and sweeteners group Tate & Lyle following a 'constrained' third-quarter trading update in which it scaled back its profit guidance for the full year. The company said that, despite a solid start to the final quarter, constant-currency profits
Read moreUK stocks retreat from three-week high as earnings disappoint
13th Feb 2014 08:30
- Stocks snap six-day winning streak - Tate & Lyle, Rolls-Royce, Lloyds and Rio fall after updates - AMEC, Imperial rise techMARK 2,817.35 -0.49% FTSE 100 6,649.80 -0.38% FTSE 250 15,999.35 -0.50% UK stocks opened with moderate losses on Thursday after poorly-received results and updates from a nu
Read moreFTSE to pare recent gains ahead of quiet session
13th Feb 2014 07:18
- Small losses ahead of quiet session - Yellen testimony postponed - Attention to turn to German CPI and Greek unemployment The FTSE is set to open in the red this morning ahead of what is expected to be a fairly quiet day. City sources predict the FTSE 100 will open 17 points lower than yesterda
Read moreTate & Lyle forecasts flat FY profits as Splenda prices weaken - UPDATE
13th Feb 2014 07:11
- Solid start to Q4 trading - Price falls to deepen for its Splenda sucralose sweetener product - Full-year expected to be broadly in line with last year Food and sweetener company Tate & Lyle said it made a solid start to the final quarter, despite weakness in Splenda sucralose pricing, and expec
Read moreLondon close: Strategists surprised by recent losses in markets
7th Feb 2014 17:08
- Mixed US employment data - Barclays: Fed could refrain from tapering in March - Persimmon and LSE shares power ahead - NIESR: MPC will not raise rates until quarter two of 2015 techMARK 2,790.30 +0.40% FTSE 100 6,571.68 +0.20% FTSE 250 15,865.12 +0.48% The FTSE 100 managed to end the day in the
Read moreBroker tips: Shire, Tate & Lyle, Aquarius Platinum, Acal
7th Feb 2014 12:22
Jefferies has kept its 'buy' rating for pharmaceuticals group Shire saying that it still sees 'attractive growth', but was disappointed by the outcome of clinical trials for the company's major depressive disorder (MDD) treatment, Vyvanse. "We were more optimistic for expanded use of Vyvanse in maj
Read moreLondon midday: Stocks flat as investors await US data with caution
7th Feb 2014 11:41
- Markets flat ahead of US jobs report - Stocks pause after ECB-inspired rally on Thursday - Data disappoints from China, UK, Germany techMARK 2,788.33 +0.33% FTSE 100 6,564.10 +0.09% FTSE 250 15,837.69 +0.30% The FTSE 100 was more or less flat by midday on Friday after trading within a narrow ran
Read moreFriday broker round-up UPDATE
7th Feb 2014 09:30
Acal: N+1 Singer initiates with a target price of 380p and a buy recommendation. AstraZeneca: Societe Generale ups target price from 3030p to 3126p, but still recommends selling. Barratt Developments: Deutsche Bank raises target price from 394p to 480p keeping a buy recommendation. Beazley: Canac
Read more